Eugenie S. Kleinerman
- Molecular Biology top 2%
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 0.5%
- Immunology top 1%
- Cancer Research top 1%
- Co-authors
- Zhichao ZhouIsaiah J. FidlerShu-Fang JiaLaura L. WorthNancy GordonNadezhda V. KoshkinaBrock A. LindseyJustin Markel
- Topics
- Sarcoma Diagnosis and Treatment (52 papers)RNA Interference and Gene Delivery (33 papers)Immunotherapy and Immune Responses (26 papers)
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- United StatesJapanAustralia
In The Last Decade
Eugenie S. Kleinerman
212 papers receiving 7.6k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Molecular Biology 3.2k
- Oncology 2.8k
- Pulmonary and Respiratory Medicine 2.4k
- Immunology 2.4k
- Cancer Research 1.3k
Countries citing papers authored by Eugenie S. Kleinerman
This map shows the geographic impact of Eugenie S. Kleinerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugenie S. Kleinerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugenie S. Kleinerman more than expected).
Fields of papers citing papers by Eugenie S. Kleinerman
This network shows the impact of papers produced by Eugenie S. Kleinerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugenie S. Kleinerman. The network helps show where Eugenie S. Kleinerman may publish in the future.
Co-authorship network of co-authors of Eugenie S. Kleinerman
This figure shows the co-authorship network connecting the top 25 collaborators of Eugenie S. Kleinerman. A scholar is included among the top collaborators of Eugenie S. Kleinerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugenie S. Kleinerman. Eugenie S. Kleinerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 6 | |
| 3 | 2 | |
| 4 | 84 | |
| 5 | 32 | |
| 6 | 15 | |
| 7 | 21 | |
| 8 | 12 | |
| 9 | 12 | |
| 10 | 131 | |
| 11 | 18 | |
| 12 | 32 | |
| 13 | 28 | |
| 14 | Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Groupbreakdown → | 520 |
| 15 | 32 | |
| 16 | 11 | |
| 17 | E1A sensitizes HER2/neu-overexpressing Ewing's sarcoma cells to topoisomerase II-targeting anticancer drugs. | 50 |
| 18 | 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice. | 85 |
| 19 | Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration. | 37 |
| 20 | Effect of virus infection on the inflammatory response. Depression of macrophage accumulation in influenza-infected mice. | 45 |
About Eugenie S. Kleinerman
Eugenie S. Kleinerman is a scholar working on Immunology, Oncology and Immunology and Allergy, having authored 212 papers that have together received 7.9k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (52 papers), RNA Interference and Gene Delivery (33 papers) and Immunotherapy and Immune Responses (26 papers). The work is most often cited by research in Immunology (2.4k citations), Oncology (2.8k citations) and Cancer Research (1.3k citations). Eugenie S. Kleinerman has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include Zhichao Zhou, Isaiah J. Fidler, Shu-Fang Jia, Laura L. Worth, Nancy Gordon, Nadezhda V. Koshkina, Brock A. Lindsey, Justin Markel, Hui Guan and Xiaoping Duan. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.